Simple Summary Many epidemiological studies have examined the relationship between
cutaneous malignant melanoma (CMM) and both endogenous oestrogen exposure (eg, age …

Epidemiological findings on the effects of hormones on melanoma risk have been
inconsistent. We therefore conducted a meta-analysis to examine the relationship between …

A number of studies have focused on possible relationships between characteristics of
female endocrine status and melanoma (CM) risk; however, the link between melanoma …

Although primary cutaneous melanoma accounts for approximately 3% of all malignant skin
tumors, it has the greatest contribution to skin cancer–related death. Sex-specific differences …

Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but
epidemiologic findings are conflicting. We examined the associations between use of oral …

Background Multiple studies showed conflicting results on the association between oral
contraceptive (OC) use and the development of cutaneous melanoma (CM). We investigated …

Cutaneous melanoma has been suspected to be influenced by female hormones. Several
studies reported a positive association between menopausal hormone therapy (MHT) use …

A favourable option to management symptoms during menopausal transition is menopausal
hormone therapy (MHT) but relation among MHT and risk of melanoma is controversial. This …

The association between use of menopausal hormone therapy (HT) and occurrence of skin
malignant melanoma (SMM) is controversial. We investigated the issue in a nationwide …

Background Currently, the association between body mass index (BMI) and hormone
therapies and Cutaneous Melanoma (CM) development is strongly debated. This study was …